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Chloride has an important role in regulating vacuolar
Hþ -ATPase activity across specialized cellular and
intracellular membranes. In the kidney, vacuolar Hþ -ATPase
is expressed on the apical membrane of acid-secreting
A-type intercalated cells in the collecting duct where it has
an essential role in acid secretion and systemic acid base
homeostasis. Here, we report the identification of a chloride
transporter, which co-localizes with and regulates the activity
of plasma membrane Hþ -ATPase in the kidney collecting
duct. Immunoblotting and immunofluorescent labeling
identified Slc26a11 (B72kDa), expressed in a subset
of cells in the collecting duct. On the basis of double-
immunofluorescent labeling with AQP2 and identical
co-localization with Hþ -ATPase, cells expressing Slc26a11
were deemed to be distinct from principal cells and were
found to be intercalated cells. Functional studies in
transiently transfected COS7 cells indicated that Slc26a11
(designated as kidney brain anion transporter (KBAT)) can
transport chloride and increase the rate of acid extrusion by
means of Hþ -ATPase. Thus, Slc26a11 is a partner of vacuolar
Hþ -ATPase facilitating acid secretion in the collecting duct.
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SLC26(human)/Slc26(mouse) isoforms belong to a con-
served family of anion transporters and are expressed in
various tissues and organs, with some paralogs displaying
specific tissue, cell, or subcellular expression pattern.1–8
SLC26 isoforms can transport various anions, including
chloride, sulfate, bicarbonate, and oxalate, with variable
specificity.9,10 Several SLC26A members function as chloride/
bicarbonate exchangers. These include SLC26A3 (DRA),
SLC26A4 (pendrin), SLC26A6 (PAT1), SLC26A7, and
SLC26A9.11–18 SLC26A7 and SLC26A9 can also function as
chloride channels.18–21 Several SLC26 isoforms can transport
oxalate, including SLC26A6 (PAT1), A7, A8, and A9.22–26
SLC26 family members share a signature sequence on their
C-terminal domain, which is referred to as sulfate transporter
and anti-sigma factor domain and has an important role in
transport function.1–10
At present, little is known about SLC26A11, other than
that its mRNA is expressed in several tissues including
the placenta, kidney, and venules, and can transport sulfate.8
No studies have examined the cellular distribution and
subcellular localization of SLC26A11 in the kidney or in any
other tissues. Furthermore, the affinity of SLC26A11 for
chloride transport or Cl/HCO3
 exchange, and its ability to
facilitate any biological process remain unknown.
Vacuolar Hþ -ATPase is expressed in the plasma membrane
of specialized cells such as osteoclast and kidney collecting
duct intercalated cells (review).27,28 The secretion of acid
through Hþ -ATPase into the lumen of the kidney collecting
duct, and connecting, distal convoluted and proximal tubule
has an essential role in systemic acid base homeostasis.29–31
It is well established that chloride has an important role in
regulating the activity of V Hþ -ATPase expressed in the
cellular and intracellular membranes.32–35 The effect of
chloride is likely mediated through two distinct mechanisms.
The first is believed to be through the dissipation of a
potential difference when chloride is secreted electrogenically,
whereas the second is through a direct, specific stimulatory
role that has been less well characterized.32–36
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Our studies demonstrate that the expression of Slc26a11
in the kidney is exclusively limited to the collecting duct, with
remarkable co-localization with Hþ -ATPase in intercalated
cells. We further demonstrate that Slc26a11 mediates the
transport of chloride and can facilitate acid extrusion
through Hþ -ATPase. We propose that Slc26a11 is a
functional partner of Hþ -ATPase and regulates acid secre-
tion in the collecting duct.
RESULTS
Expression of Slc26a11
We first examined the distribution of Slc26a11 mRNA in
mouse tissues. Figure 1a is a northern hybridization indi-
cating the expression of Slc26a11 in multiple tissues, with
abundant mRNA levels in the brain and kidney, followed by
the distal colon. Next, reverse transcription-PCR experiments
were performed on RNA isolated from various kidney zones
to examine the zonal distribution of Slc26a11. The results
demonstrated the expression of Slc26a11 in the cortex
and medulla of mouse kidney (Figure 1b) as verified by
sequencing of the single 1.2-kb band. Northern hybridi-
zation verified that Slc26a11 mRNA was abundantly
expressed in the cortex and medulla (data not shown). This
pattern of expression is distinct from Slc26a6 (PAT1), which
is abundantly expressed in the cortex but is absent in the
medulla, and Slc26a7 (PAT2), which is expressed in the
medulla but not in the cortex.16,17
Mouse Slc26a11 has two distinct variants (GenBank
accession numbers: AF345196 and BC132493) with the long
variant having an additional 170 amino acids (aa) on its
N-terminal end. In the next series of experiments, we
examined the tissue distribution of long and short variants
using variant-specific radiolabeled DNA probes (Materials and
Methods). Figure 1c is a northern hybridization and shows
that the long variant is predominantly expressed in the kidney
and in several other epithelial tissues, including the brain.
However, the short variant is predominantly expressed in the
brain with lower levels in the kidney (Figure 1d). Given its
abundant expression in the kidney and brain and its functional
activity as an anion transporter (see below), we wish to
designate Slc26a11 as KBAT (kidney brain anion transporter).
Immunoblotting and immunofluorescent labeling
of Slc26a11 (KBAT) in the kidney
Using an antibody generated against the mouse Slc26a11, a
72-kDa band was detected in microsomal membrane proteins
from the renal medulla (Figure 2a, left panel). The labeling
of the 72-kDa band was completely prevented with the pre-
adsorbed immune serum (Figure 2a, left panel). To examine
the specificity of the Slc26a11 antibody further, COS7 cells
were transfected with the full-length Slc26a11 cDNA, labeled
with Slc26a11 antibodies, and co-labeled with phalloidin-
tetramethylrhodamine, a marker of the actin cytoskeleton.
Images were taken on a Zeiss LSM510 confocal microscope
(Zeiss, Thornwood, NY) and analyzed as before.17 As
indicated (Figure 2a, right panel), the Slc26a11 antibodies
specifically label the plasma membrane of cells transfected
with the Slc26a11 cDNA but not with the empty vector.
To determine the cellular distribution and subcellular
localization of KBAT, immunofluorescent staining with the
purified immune serum was performed in the kidney. As
shown in Figure 2bA–C, low-magnification images detected
the expression of KBAT in a subset of cells in the collecting
duct in the cortex, outer medulla, and inner medulla.
As demonstrated in images with higher magnification,
the labeling of KBAT in the cortex was detected on either
the apical or the basolateral membrane domains in collec-
ting duct cells (Figure 2cA), whereas the labeling of KBAT
in the outer medullary collecting duct and inner medul-
lary collecting duct was exclusively limited to the apical
membrane (Figure 2cB and C). The labeling with KBAT
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Figure 1 | Slc26a11 distribution in mouse tissues and kidney.
(a) Tissue distribution of Slc26a11. Slc26a11 transcript size was
2.0 kb. Slc26a11 was detected abundantly in the kidney and brain,
followed by upper small intestine and distal colon. 28S rRNA levels
are shown as constitutive controls. In all, 30 mg of RNA was loaded
on each lane. (b) Kidney expression of Slc26a11 by RT-PCR.
A representative ethidium bromide staining of agarose gel
demonstrates a PCR product of expected size (1200 bp) in the
cortex and medulla. (c) Tissue distribution of the Slc26a11 long
variant. The long Slc26a11 variant is expressed in the kidney and
other epithelial cells, with lower levels in the brain. (d) Tissue
distribution of the Slc26a11 short variant. The short Slc26a11
variant is predominantly expressed in the brain, with lower levels
in other tissues. RT-PCR, reverse transcriptase-PCR.
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antibodies was specific, as pre-adsorbed immune serum
failed to detect any labeling in the kidney (Figure 2d).
To determine the identity of Slc26a11-expressing cells,
double-immunocytochemical staining with antibodies
against Slc26a11 and aquaporin 2 (AQP2), which is exclu-
sively expressed on the apical membrane of principal cells,
was performed. As shown in Figure 3aA (the cortex, outer
medulla, and inner medulla), KBAT (left) and AQP2 (right)
clearly localized to two distinct cell populations in the
cortical collecting duct (Figure 3aA), outer medullary
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collecting duct (Figure 3aB), and inner medullary collecting
duct (Figure 3aC) (merged images in the middle), clearly
demonstrating that cells expressing KBAT (Slc26a11) are
distinct from principal cells. An obvious conclusion from
these studies is that Slc26a11 (KBAT) is located in
intercalated cells in the collecting duct. To examine this issue
Figure 2 | Immunolocalization of Slc26a11 (KBAT) in the kidney. (a) Specificity of KBAT antibodies and immunoblotting of KBAT in the
kidney. Left panel: with the use of the antibody generated against the mouse Slc26a11, a B72-kDa band was detected in the kidney
medulla. Labeling of the 72-kDa band was completely prevented with the pre-adsorbed immune serum. Right panel: KBAT antibody
specifically labels the plasma membrane of COS7 cells transfected with Slc26a11 cDNA. Top: cells transfected with empty vector (sham),
bottom: cells transfected with Slc26a11 cDNA. Cells were labeled with KBAT antibodies (Slc26a11, left) and co-labeled with phalloidin (right),
as a marker of the actin cytoskeleton. (b) Immunofluorescent labeling with KBAT antibodies (low magnification). Low magnification of
Slc26a11 labeling in the cortex (A, left), outer medulla (B, middle), and the inner medulla (C, right). (c) Immunofluorescent labeling with
KBAT antibodies (high magnification). Higher magnifications of Slc26a11 labeling in the cortex (A, left), outer medulla (B, middle), and the
inner medulla (C, right). Results clearly demonstrate that in the cortex, the labeling of KBAT was detected on the apical or basolateral
membrane domains in the CCD (arrows). In the medulla, KBAT was only detected on the apical membrane domain of a subset of cells in
OMCD (B) and IMCD (C) (arrows). (d) Immunolabeling with pre-adsorbed immune serum. No labeling was detected with the pre-adsorbed
immune serum in the cortex (A) and in the medulla (B and C). CCD, cortical collecting duct; IMCD, inner medullary collecting duct; KBAT,
kidney brain anion transporter; OMCD, outer medullary collecting duct.
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Figure 3 | Immunofluorescent double staining of KBAT with AQP2 or Hþ -ATPase. (a) Double immunofluorescent labeling of KBAT and
aquaporin 2 (AQP2) in the kidney. (A) Cortex (top). Immunostaining in the kidney indicated that the distribution of AQP2 (right, purple
arrow) and Slc26a11 (left, white arrow) corresponded to two distinct cell subtypes in the CCD when dual images were acquired (middle). (B
and C) Outer medulla (B) and inner medulla (C). Immunostaining in the kidney indicated that the distribution of AQP2 (right, purple arrows)
and Slc26a11 (left, white arrows) corresponded to two distinct cell subtypes in the OMCD (B) and IMCD (C) when dual images were acquired
(middle), indicating that Slc26a11 is localized on the apical membrane of cells distinct from principal cells. (b) Double-immunofluorescent
labeling of KBAT and Hþ -ATPase in the kidney. (A) Cortex. Two sets of data (top and bottom panels) are shown in panel (bA). As shown,
Slc26a11 (left, white arrows) and Hþ -ATPase (right, purple arrows) demonstrate remarkably identical localization patterns in the cortical
collecting duct when merged images are acquired (middle). Slc26a11 co-localizes with Hþ -ATPase on the apical membrane of A-
intercalated cells and on the basolateral membrane of B-intercalated cells in the CCD. (B and C) Outer medulla (bB) and inner medulla (bC).
In the OMCD (bB) and IMCD (bC), Slc26a11 (left, white arrows) co-localizes with Hþ -ATPase (right, purple arrows) exclusively on the
apical membrane of A-intercalated cells (merged image in the middle). CCD, cortical collecting duct; IMCD, inner medullary collecting duct;
KBAT, kidney brain anion transporter; OMCD, outer medullary collecting duct.
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further, double-immunofluorescent labeling using KBAT and
Hþ -ATPase antibodies was performed. As demonstrated,
merged images display remarkably identical co-localization
of KBAT with Hþ -ATPase along the length of the collecting
duct (Figure 3bA–C). As shown, KBAT and Hþ -ATPase co-
localize on the apical membrane of A-intercalated cells and
on the basolateral membrane of B-intercalated cells in the
cortical collecting duct (Figure 3bA). Some cells display co-
localization of KBAT and Hþ -ATPase on the apical and
basolateral membranes of the same cells (Figure 3bA). These
latter cells most likely represent non-A-, non-B-intercalated
cells, based on the reported Hþ -ATPase expression pattern.
The co-localization of Hþ -ATPase and KBAT in the
outer medullary collecting duct (Figure 3bB) and the initial
portion of inner medullary collecting duct (Figure 3bC) was
exclusively detected on the apical membrane of A-inter-
calated cells, consistent with the loss of non-A-intercalated
cells in medullary collecting ducts. These results clearly
demonstrate the co-localization of Slc26a11 (KBAT) with
Hþ -ATPase in the collecting duct.
Functional examination of Slc26a11 (KBAT)
To ascertain the functional identity of KBAT, COS7 cells were
transiently transfected as described in the ‘Materials and
Methods’ section. We first tested whether Slc26a11 has
the ability to transport chloride. Toward this end, 24-well
plates transfected with KBAT cDNA were used for 36Cl influx
and efflux experiments as described in the ‘Materials and
Methods’ section. As shown in Figure 4a, cells transiently
transfected with Slc26a11 cDNA demonstrated increased
uptake of 36Cl vs mock-transfected cells (Po0.02, n¼ 6).
The 10-min influx of 36Cl was significantly inhibited by
0.5mmol/l 4,40-Diisothiocyano-2,20-stilbenedisulfonic acid
(DIDS) in transfected cells (Figure 4a). We next examined
the role of Slc26a11 in chloride efflux across the cell
membrane in the absence or presence of external chloride.
In the absence of extracellular chloride (all chloride salts were
replaced with gluconate salts), Slc26a11-expressing cells
demonstrated significant 36Cl efflux relative to mock-trans-
fected cells, when an outwardly directed potassium gradient
which causes depolarization (extracellular K¼ 1mmol/l) was
imposed, as shown in Figure 4b. In the presence of extracellular
chloride (100mmol/l Cl), the efflux of 36Cl was significantly
increased in Slc26a11-transfected vs mock-transfected cells
(Po0.01, n¼ 6) (Figure 4b). This (Cl)o/(36Cl)i exchange-
mediated efflux was42-fold higher relative to the absence of
external chloride (Figure 4b). These results indicate that
KBAT can function as an anion exchanger and as an
electrogenic chloride-extruding pathway.
To examine the effect of membrane potential alteration
on KBAT, 36Cl efflux experiments were carried out under
voltage-clamped conditions using valinomycin, a Kþ -specific
ionophore, and a Kþ -rich solution and compared with a low
Kþ extracellular solution. The efflux of 36Cl was assayed in
the presence or absence of chloride in the external solution.
As shown in Figure 4c (left panel), in the absence of the
external chloride but in the presence of valinomycin and
Kþ -rich solution, 36Cl efflux in KBAT-transfected cells was
significantly inhibited vs outwardly directed K gradient, and
was not different relative to non-transfected cells (n¼ 6,
P40.05). These results strongly suggest that the unidirec-
tional chloride efflux (likely mediated through a conductive
pathway) was regulated by membrane potential and is
abrogated under voltage-clamped conditions. However, the
efflux of 36Cl in the presence of external chloride was only
partially inhibited under voltage-clamped conditions in
KBAT-transfected cells (n¼ 6, Po0.05 vs mock-transfected
cells; Figure 4c, right panel), indicating that the KBAT-
mediated anion exchange pathway is in a large part indepen-
dent of membrane potential alteration. The 36Cl efflux in the
presence or absence of extracellular chloride was significantly
inhibited by 0.5mmol/l DIDS.
Given the ability of KBAT to function as an anion
exchanger (Figure 4b and c), we sought to determine whether
KBAT could function in the Cl/HCO3
 exchange mode.
Toward this end, COS7 cells were plated on coverslips and
transiently transfected with KBAT cDNA. After 48 h, cells
were loaded with the pH-sensitive dye BCECF (20,70-bis-
(2-carboxyethyl)-5-(and-6)-carboxyfluorescein) and their
intracellular pH (pHi) was monitored as described in the
‘Materials and Methods’ section. Our results demonstrated
that in the presence of CO2/HCO3
 in the solutions,
sequential switching of the perfusate to chloride-free and
chloride-containing solutions induced a significant pHi
alteration in KBAT-transfected cells relative to mock-
transfected cells (Figure 4d). The summation of six separate
coverslips showed that in the presence of CO2/HCO3
 in
the media, the rate of intracellular alkalinization in response
to chloride removal was 0.13±0.015 pH/min in KBAT-
transfected and 0.04±0.007 in mock-transfected cells
(Po0.02, n¼ 6, Figure 4e). In the absence of CO2/HCO3
in the media, the same maneuver did not elicit any significant
pHi alteration (Figure 4e). In bicarbonate-free solutions,
bi (buffering power) was 27.2±3.1mmol/l per pH unit in
transfected and 28.7±3.4mmol/l per pH unit in non-
transfected cells (n¼ 3 for each group, P40.05). In the
presence of bicarbonate in the media, the total buffer capacity
was 85.4±6.1mmol/l in transfected and 82.4±5.9mmol/l
in non-transfected cells (n¼ 3, P40.05). Taken together,
these results are consistent with KBAT functioning in the
Cl/HCO3
 exchange mode.
In the last series of experiments, we examined the effect of
KBAT on Hþ -ATPase activity. Toward that end, cultured
COS7 cells were plated on coverslips, transiently transfected
with KBAT cDNA, and their pHi was examined 48 h later
by the pH-sensitive dye BCECF. To monitor Hþ ATPase
activity, cells were first acid loaded by NH4 pulse technique
and then switched to a hypotonic Na-free solution. Under
these conditions, pHi recovery from intracellular acidosis is
exclusively mediated through Hþ -ATPase as determined by its
sodium independence (Figure 5a) and its inhibition in
the presence of bafilomycin (ref. 37 and personal observation).
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Figure 4 | Functional identity of Slc26a11 (KBAT). COS7 cells were transiently transfected with KBAT cDNA and studied by 36Cl flux assay
(a–c) and intracellular pH monitoring (d and e). (Panel a) 36Cl influx. Cells were transiently transfected with Slc26a11 (KBAT) cDNA and
assayed 48 h later. The influx of 2mmol/l 36Cl was stopped at 10min using cold saline. The nonspecific Cl uptake (background) was
calculated in both transfected and non-transfected cells at time 0 and deducted from their respective 10-min influx values. As shown, cells
transfected with KBAT demonstrated significant 36Cl influx relative to mock-transfected cells. The presence of DIDS significantly inhibited
the 36Cl influx. Extracellular K¼ 4mEq. (Panel b) 36Cl efflux (in the absence or the presence of external chloride). Cells were transiently
transfected with Slc26a11 (KBAT) cDNA and assayed 48 h later. Cells were first pre-incubated with 2mmol/l 36Cl for 30min. Thereafter, the
radioactive media were aspirated and cells were washed three times in rapid succession and then incubated with a chloride-free or a
chloride-containing solution. The reaction was stopped at time 0 or 10min. The chloride efflux was calculated as the difference in cell
chloride count at time zero (control) and 10min. As shown, cells transfected with KBAT demonstrated significant amount of 36Cl efflux
relative to mock-transfected cells, when an outwardly directed potassium gradient (extracellular K¼ 1mEq) was imposed. In the presence of
external chloride (100mmol/l), the rate of 36Cl efflux was significantly increased relative to no external chloride. (Panel c) Effect of voltage
clamping on 36Cl efflux in the presence or absence of external chloride. Cells were transiently transfected and then loaded with 2mmol/l
36Cl for 30min as above. Cells were pre-incubated with 10 mmol/l valinomycin or ethanol (as vehicle). The 10-min efflux of 36Cl was assayed
in the presence or absence of potassium-rich (100 or 5mmol/l KCl) solution. The unidirectional chloride efflux by KBAT was abrogated,
and the anion exchange mode of KBAT was partially inhibited under voltage-clamped conditions. (Panel d) Intracellular pHi monitoring.
Cl/HCO3
 exchanger activity was assayed by subsequent removal and addition of Cl as described in the ‘Materials and Methods’ section.
The experiments were repeated in the absence of CO2/HCO3
 (see below). Both the intracellular alkalinization upon chloride removal and
the pHi recovery upon switching back to chloride-containing solution were increased in KBAT-transfected cells. In the absence of
bicarbonate, the rate of pHi alteration was minimal in both sham and KBAT-transfected cells (below). (Panel e) Summation of pHi tracing
studies. In the presence of CO2/HCO3
 in the media, the rate of chloride-dependent bicarbonate transport was significantly increased
in KBAT-transfected cells relative to mock-transfected cells. In the absence of CO2/HCO3
 in the media, the rate of chloride-dependent
pHi alteration was minimal in both KBAT-transfected and non-transfected cells. Buffering capacity (bi) was calculated in mock and
KBAT-transfected cells according to established protocols and was not different between the two groups. DIDS, 4,40-Diisothiocyano-2,20-
stilbenedisulfonic acid; KBAT, kidney brain anion transporter; pHi, intracellular pH; Valino, valinomycin.
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As indicated, KBAT-transfected cells show an Hþ -ATPase
activity, which was significantly increased relative to mock-
transfected cells (Figure 5a). The results of six separate
experiments demonstrated that the rate of Hþ -ATPase-
mediated acid extrusion increased by B70% in KBAT-
transfected cells (Po0.03, n¼ 6) (Figure 5b).
To examine the role of KBAT as a chloride transporter
on Hþ -ATPase activity, cells were acid loaded and then
assayed for pHi recovery in a chloride-depleted solution that
in addition was sodium free (see the ‘Materials and Methods’
section). The results demonstrate that Hþ -ATPase activation
by KBAT was almost abolished in chloride-depleted cells
(Figure 5c, middle panel vs left panel). As indicated, mock-
transfected cells showed moderate inhibition, whereas KBAT-
transfected cells showed significant inhibition of Hþ -ATPase
activity under chloride-depleted conditions.
To further ascertain the role of KBAT on Hþ -ATPase
activation, cells were monitored for pHi recovery from intra-
cellular acidosis as described above in the presence of
0.5mmol/l DIDS. Our results demonstrate that the rate of
Na-independent, bafilomycin-sensitive pHi recovery from
acidosis (Hþ -ATPase activity) was significantly blunted in
cells transfected with KBAT (Figure 5c, right panel vs left
panel). As indicated, mock-transfected cells showed mild
inhibition, whereas KBAT-transfected cells showed significant
inhibition of their Hþ -ATPase activity by DIDS.
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Figure 5 | Effect of Slc26a11 (KBAT) on Hþ -ATPase activity (pH studies). (a) Intracellular pH tracing. Cultured COS7 cells were acid
loaded with NH4þ pulse in the presence of Na-free (TMA)-Cl. Switching from the isotonic, Na-free solution to hypotonic, Na-free solution
resulted in pHi recovery in mock-transfected, acid-loaded cells (left). KBAT-transfected cells showed a more robust recovery from the
acid-loaded state when switched to the hypotonic Na-free solution (right). (b) KBAT-transfected vs mock-transfected cells: Summation
of results. Summation of recovery rates from acidosis from six separate coverslips showed that Hþ -ATPase-mediated pHi recovery from
intracellular acidosis was significantly increased in KBAT-transfected cells. (c) Characterization of KBAT activation of Hþ -ATPase. Effect
of chloride-free solution on KBAT activated Hþ -ATPase. Control and KBAT-transfected COS7 cells were acid loaded, depleted of chloride,
and then monitored for the recovery from intracellular acidosis in the absence of chloride in the external solution. KBAT stimulation of
Hþ -ATPase activity was almost abrogated in the chloride-depleted state. Effect of DIDS on KBAT activated Hþ -ATPase. pHi recovery from
intracellular acidosis was monitored in control and KBAT-transfected COS7 cells in the presence of 0.5mmol/l DIDS added to the external
solution. Effect of voltage clamping on KBAT activated Hþ -ATPase. Control and KBAT-transfected COS7 cells were pre-incubated
with valinomycin at 10 mmol/l. Cells were acid loaded and then monitored for recovery from intracellular acidosis in a high-potassium,
chloride-containing solution. As shown, KBAT stimulation of Hþ -ATPase was partially inhibited under voltage clamped conditions.
DIDS, 4,40-Diisothiocyano-2,20-stilbenedisulfonic acid; KBAT, kidney brain anion transporter; pHi, intracellular pH.
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To determine whether KBAT activation of Hþ -ATPase
is mediated through its electrogenic transport of chloride,
the experiments were repeated in the presence of high
potassium in the perfusion solution (70mmol/l Kþ ) and
valinomycin at 10 mmol/l (Materials and Methods). As shown
in Figure 5c (right panel), the dissipation of membrane
potential by increased external potassium and valinomycin
only partially blocked the stimulation of Hþ -ATPase by
KBAT. Taken together, these results strongly indicate that
Hþ -ATPase activation of KBAT is dependent on intracellular
chloride and is partially affected by alterations in membrane
potential.
DISCUSSION
The present studies identify Slc26a11 (KBAT) as a potential
functional partner for V Hþ -ATPase in the kidney collecting
duct. KBAT displays remarkable co-localization with Hþ -
ATPase in the kidney collecting duct and is able to transport
chloride when expressed in cultured cells. KBAT was able
to function as an anion exchanger and as an electrogenic
chloride-extruding pathway. KBAT enhanced the Hþ -
ATPase-mediated acid extrusion by a chloride-dependent
mechanism in cultured cells.
The kidney collecting duct has an essential role in acid
base transport and systemic pH homeostasis. This important
function occurs by secretion of acid into the lumen,
predominantly by vacuolar Hþ -ATPase.28,29 The abundance
of vacuolar Hþ -ATPase in the apical membrane of inter-
calated cells is mainly controlled by exocytic insertion or
endocytic withdrawal of the pump. Studies in various animal
models have provided support for this mechanism by
showing redistribution of Hþ -ATPase in the collecting duct
in response to increased acid or alkali intake.37
Vacuolar Hþ -ATPase is an electrogenic pump, indicating
that its operation creates an electrical potential difference
across the membrane. It has been suggested that the
continued secretion of acid through Hþ -ATPase requires
that the lumen-positive voltage resulting from electrogenic
Hþ secretion be dissipated, predominantly by the secretion
of an anion (such as Cl) or by the absorption of a cation
(such as Naþ ).32,35
The presence of a chloride channel facilitating the secre-
tion of acid through Hþ -ATPase in lysosomes, endosomes,
and the trans-Golgi network has been well documented.38–46
The intra-organelle acidification in these compartments by
vacuolar Hþ -ATPase requires the activity of a parallel
chloride ion channel to dissipate the membrane potential
generated by proton translocation.38–44
Recent studies have indicated an important role for
chloride in regulating the activity of plasma membrane
Hþ -ATPase in the kidney proximal tubule and the collecting
duct. In microperfused rat proximal tubule, intracellular
chloride depletion resulted in a significant inhibition of
Hþ -ATPase activity.34 Studies in microperfused rabbit
proximal tubule have shown that chloride depletion or the
addition of chloride channel blocker significantly inhibited
vacuolar Hþ -ATPase activity.33 These results indicate that
chloride has an important role in vacuolar Hþ -ATPase
regulation in kidney tubules.33,34 In microperfused late distal
tubule, which expresses electrogenic Hþ -ATPase and con-
tains intercalated cells, the inhibition of apical Cl conduc-
tance by 5-nitro-2-(3-phenylpropylamino) benzoic acid
(NPPB) significantly altered the luminal membrane poten-
tial.32,45,46 Furthermore, blocking the apical Cl conduc-
tance reduced the rate of bicarbonate reabsorption in this
segment by 450%.45,46 These results indicate that an apical
Cl conductance pathway is active and has an important role
in acid secretion through Hþ -ATPase in the collecting duct.
However, no studies have identified any chloride transporter/
conductance candidate molecule as the functional partner
for Hþ -ATPase in kidney intercalated cells.
It is worth mentioning that the role of chloride in Hþ -
ATPase stimulation is not explained solely by dissipation of
a potential difference across the plasma membrane; recent
experiments support a direct, specific role of Cl in stimu-
lating Hþ -ATPase activity. These studies have shown that
even after dissipating the potential difference across endo-
some membranes, Hþ -ATPase still depends on the presence
of Cl ions. These findings suggest a chloride-binding site in
an intra-membrane pump sector.
Our studies indicate that the presence of DIDS signi-
ficantly inhibited Hþ -ATPase-mediated acid extrusion in
COS7 cells transfected with KBAT (Figure 5c), strongly
supporting a regulatory role for KBAT on Hþ -ATPase
activity. Our current results (Figure 5c) further indicate that
in the presence of the potassium ionophore valinomycin and
a Kþ -rich external solution, the stimulatory effect of KBAT
on Hþ -ATPase activity remained largely intact. We could not
find any significant Cl/Hþ exchange activity by pHi
monitoring in COS7 cells transfected with KBAT (data not
shown); therefore, we do not believe that KBAT is a Cl/Hþ
exchanger.
Our experiments clearly demonstrate the exclusive
localization of KBAT in collecting duct intercalated cells
(Figures 1–3). Furthermore, our immunolocalization studies
unequivocally demonstrate the co-localization of Hþ -ATPase
and KBAT in kidney intercalated cells (Figures 2 and 3). This
co-localization has significant functional ramification as
shown by enhanced Hþ -ATPase activity in cells transfected
with Slc26a11 (Figure 5).
In addition to the electrogenic chloride transport,
KBAT functions as an anion exchanger, both with 36Cl flux
(Figure 4b and c) and pHi monitoring methods (Figure 4d
and e). This anion exchange mode likely represents a
Cl/HCO3
 exchanger (Figure 4d and e). The multi-anion
transport capabilities of KBAT is in agreement with proper-
ties shown by several other Slc26 family members, and
specifically resembles Slc26a9, which can function as an
electrogenic Cl/HCO3
 exchanger and as a chloride
channel.9,18,19,21 Given its ability to mediate Cl/HCO3

exchange and its localization on the basolateral membrane of
non-A-intercalated cells in cortical collecting duct (Figure 3),
Kidney International (2011) 80, 926–937 933
J Xu et al.: Slc26a11 (KBAT) co-localizes with Hþ -ATPase in the kidney o r ig ina l a r t i c l e
we propose that KBAT is the basolateral Cl/HCO3

exchanger in non-A- and non-B-intercalated cells, which
are shown to express the Cl/HCO3
 exchanger on both their
apical and basolateral membranes.27–31
In addition to kidney intercalated cells, bone-resorbing
osteoclasts are one of the few mammalian cells that express
V Hþ -ATPase on their apical membrane.47 Given the
remarkable co-localization of Hþ -ATPase and Slc26a11 in
kidney intercalated cells (Figures 1–3) and given the many
similarities between the regulatory pathways of Hþ -ATPase
in intercalated cells and osteoclasts,27,28,47 we entertained
the possibility that Slc26a11 is expressed in osteoclasts. Our
reverse transcriptase-PCR, northern hybridization, western
blotting, and immunofluorescence labeling studies demon-
strate that KBAT is abundantly expressed in osteoclasts and
co-localizes with Hþ -ATPase on its ruffled membrane
(manuscript in preparation).
KBAT shows abundant expression in the brain and
noticeable expression in the distal colon (Figure 1). The cell
distribution of KBAT in the brain remains speculative.
However, given the expression of Hþ -ATPase in the brain,48
it is intriguing to speculate a co-localization and possibly a
co-regulation of KBAT and Hþ -ATPase in brain cells. With
regard to the colon, we speculate that this transporter could
be expressed on the apical membrane of colonocytes and
might have a role in chloride secretion.
In conclusion, Slc26a11 (KBAT) mediates electrogenic
transport of chloride, localizes with Hþ -ATPase in inter-
calated cells, and facilitates acid secretion. In addition, KBAT
can function in the Cl/HCO3
 exchange mode. We propose
that Slc26a11 (KBAT) facilitates Hþ -ATPase-mediated acid
secretion in the collecting duct, either by dissipating the
membrane potential resulting from Hþ secretion with
electrogenic chloride transport or directly through mechan-
ism(s) that warrant further examination. In addition, KBAT
is likely the basolateral Cl/HCO3
 exchanger in non-A- and
non-B-intercalated cells in the cortical collecting duct.
MATERIALS AND METHODS
Animal models
C57BL/6 mice at 25–30 g body weight (and Sprague Dawley
rats at 150–200 g body weight) were used for these studies.
Animals were allowed free access to water and food. The use
of anesthetics (pentobarbital sodium) and the method of
euthanasia (pentobarbital sodium overdose) were approved
according to the institutional guidelines.
PCR of Slc26a11
Total RNA was prepared from the mouse kidney, poly(A)þ -,
selected using Oligotex latex beads (Qiagen, Valencia, CA)
and then reverse transcribed at 47 1C using SuperScript II RT
(Life Technologies, Carlsbad, CA) and oligo(dT) primers.
Oligonucleotide primers (50-TATCATGTCTCTCCTGGTGT
CC-sense and 50-ATCAATTGCAGGGAAGTACAGG-anti-
sense) were designed based on mouse Slc26a11 sequence
(GenBank accession number: AF345196). The cycling para-
meters were 94 1C for 1min, then 94 1C for 30 s, followed by
68 1C for 2min for 35 cycles. After PCR, the product was gel
purified (revealing a single band of 1.2 kb) and used as a
probe for northern blot hybridizations. Sequence analysis of
the PCR products verified the sequence as mouse KBAT,
which corresponded to the common domain for the short
and long variants (see below).
The primers for mouse-specific Slc26a11 variants were as
follows: long variant (593 aa), 50-CTCTGTGAAAGGTCTG
GGTC (sense) and 50-CAGGGCAGGAGATGAAGTC (anti-
sense) (GenBank accession number: AF345196); short variant
(420 aa), 50-GGCCAATTGTCCAGTTACCATG (sense) and
GAGGAAAGAGGAGTGGTAGGG (antisense) (GenBank
accession number: BC132493). The purified fragments were
used as variant specific probes for northern hybridization.
RNA isolation and northern blot hybridization
Total cellular RNA was extracted from various mouse kidney
zones (the cortex, outer medulla, and inner medulla) accor-
ding to established methods, quantitated spectrophotome-
trically, and stored at 80 1C. Total RNA samples (30 mg per
lane) were fractionated on a 1.2% agarose-formaldehyde gel,
transferred to Magna NT nylon membranes, cross-linked by
ultraviolet light, and baked. Hybridization was performed
according to established methods. The membranes were
washed, blotted dry, and exposed to a PhosphorImager screen
(Molecular Dynamics, Sunnyvale, CA). Slc26a11 variant-
specific 32P-labeled cDNA fragments (see above) were used
as probes for northern hybridizations. The band densities on
northern hybridization were quantitated by densitometry
using ImageQuaNT software (Molecular Dynamics).
Cloning of the full-length mouse Slc26a11
Full-length mouse Slc26a11 cDNA (long variant) was
amplified from mouse kidney RNA using the following
PCR primers: 50-CTCTGTGAAAGGTCTGGGTC (sense)
and 50-TCAGGGGCCGGAGGGAGACTT (antisense). These
primers encode nucleotides 80–1904 of a mouse Slc26a11
cDNA (GenBank accession number: AF345196) and contain
the entire open-reading frame. Amplification of the mouse
Slc26a11 cDNA by PCR was performed according to the
Clontech Advantage 2 PCR kit protocol (Clontech, Mountain
View, CA). The product was gel-purified and sequence analysis
verified its identity as Slc26a11. The PCR product was ligated
into mammalian expression pTarget Vector (Promega, Madison,
WI) for expression studies.
Cell culture and transfection procedures
For transient transfection, the full-length mouse KBAT
cDNA, subcloned into a pTarget vector, was used. COS7
cells, grown in 60-mm dishes, were transfected with 8mg of
the full-length KBAT cDNA construct according to esta-
blished methods.12,49 Cells were maintained at 37 1C in a 5%
CO2:95% O2 air incubator. Northern blots verified strong
expression of KBAT in transfected cells. Transient transfec-
tion was performed as before12,49 and cells were examined
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48 h after transfection. For experiments, cells were
grown either on coverslips or in 24-well plates at 371C and
transfected at 70% confluence with the KBAT expression
vector.
Antibody generation and immunoblot analysis
A peptide corresponding to aa 274–287 (TRDNKTISF-
SEMVQC) of mouse KBAT (GenBank accession number:
AF345196) was synthesized and used for antibody generation
in two rabbits. The pre-immune and immune sera of
the third bleed were purified by IgG purification kit (Sigma,
St Louis, MO) and used for immunoblot analysis. Membrane
and whole-cell lysates from the kidney cortex were resolved
by SDS-PAGE (30 mg per lane) and transferred to nitrocellu-
lose membrane. The membrane was blocked with 5% milk
proteins and then incubated for 6 h with 20 ml of KBAT-
immune serum diluted at 1:600. The secondary antibody was
a donkey anti-rabbit IgG conjugated to horseradish perox-
idase (Pierce, Rockford, IL). The site of antigen–antibody
complex formation on the nitrocellulose membranes was
visualized using chemiluminescence method (SuperSignal
Substrate, Pierce) and captured on light-sensitive imaging
film (Kodak, Rochester, NY). The antibody against Hþ -
ATPase is a monoclonal antibody against the 31-kDa
subunit37 and a gift from Dr Gluck (through Dr Holliday).37
The antibody against AQP217,50 is a monoclonal antibody
and a gift from Dr Ann Blanchard (Paris, France).
Immunofluorescence labeling studies
Animals were killed with an overdose of pentobarbital
sodium and perfused through the left ventricle with 0.9%
saline, followed by cold 4% paraformaldehyde in 0.1mol/l
sodium phosphate buffer (pH 7.4). Kidneys were removed,
cut in tissue blocks, and fixed in formaldehyde solution
overnight at 4 1C. The tissue was frozen on dry ice, and 6-mm
sections were cut with a cryostat and stored at 80 1C until
use. Single-immunofluorescence labeling was performed as
described previously16–18 using either Alexa Fluor 488 (green)
or Alexa Fluor 594 (red) antibody as secondary antibodies.
For double-immunofluorescence labeling, polyclonal
Slc26a11 antibodies were used in conjunction with mono-
clonal AQP2 or V Hþ -ATPase at 1:50 dilution. Slc26a11
antibodies were labeled by Alexa Fluor 594 goat anti-rabbit
IgG labeling kit and AQP-2, or Hþ -ATPase antibodies were
labeled using Alexa Fluor 488 goat anti-mouse IgG labeling
kit (Invitrogen Molecular Probes, Eugene, OR) according to
the manufacturer’s instructions.
Both frozen and paraffin-embedded sections were used for
immunolabeling. For paraffin-embedded sections, we sub-
jected the slides to antigen-retrieval protocol. Frozen kidney
sections were allowed to thaw at room temperature and were
subsequently rehydrated in phosphate-buffered saline (PBS)
for 15min and permeabilized in PBS containing 0.3% Triton
X-100 for 20min at room temperature. Nonspecific binding
was blocked with 1% bovine serum albumin in PBS for
30min. Zenon labeling complex, which was freshly prepared,
was diluted to a final dilution of 1:50 for both primary
antibodies and applied to the sections at room temperature
for 2 h in a humidified chamber. Sections were thoroughly
washed in PBS containing 0.3% Triton X-100 for 10min
three times and then in PBS for 5min two times. Sections
were fixed for the second time in 4% formaldehyde in PBS
for 15min at room temperature. Sections were then washed
and mounted in the anti-fade mounting medium (ProLong
Antifade Kit from Molecular Probes). Sections were exam-
ined and images were acquired on a Nikon PCM 2000 laser
confocal scanning microscope (Nikon, Melville, NY) as
0.5-mm ‘optical sections’ of the labeled cells.
pHi studies
Intracellular pH was monitored using the pH-sensitive
fluorescent probe BCECF-acetoxymethyl ester (Molecular
Probes), as described previously.12,35 Cultured COS7 cells
were grown on a glass coverslips and transfected with
Slc26a11 cDNA and assayed 48 h later. Cells were incubated
in the presence of 5 mmol/l BCECF in a Cl-containing,
HCO3
-free solution consisting of (in mmol/l) 115 NaCl, 25
Na-gluconate, 4 KCl, 1 K-gluconate, and 10 HEPES, at pH 7.4,
and gassed with 100% O2. The monolayer was then perfused
with the appropriate solutions at 37 1C in a Delta Scan dual
excitation spectrofluorometer (PTI, South Brunswick, NJ).
For HCO3
-containing solution, 25mmol/l Na-gluconate was
replaced iso-osmolarly with NaHCO3
 and gassed with 5%
CO2:95% O2. For the Cl
-free solution, all Cl-containing
salts were replaced with gluconate salts. All solutions
contained (in mmol/l) 0.8 K2HPO4, 0.2 KH2PO4, 1 CaCl2,
and 1 MgCl2. For Cl
-free solutions, CaCl2 and MgCl2 were
replaced with the gluconate salts. Calibration curves were
established by KCl/nigericin.12,49
The Cl/HCO3
 exchanger activity was determined by
monitoring pHi alteration in response to sequential switching
of the perfusate from chloride containing to chloride free and
then back to the chloride-containing solution, as described
previously.12 In experiments in which chloride-free solutions
were used, all chloride salts were replaced with equimolar
amounts of gluconate. Hþ -ATPase activity was assayed as the
rate of sodium-independent, bafilomycin or concanamycin-
sensitive acid extrusion, at isotonic or hypotonic sodium-free
solution after acid loading.51
Buffering power measurement in cultured cells
The intrinsic buffering power (bi; mMH
þ /pH unit) was
measured in transfected and non-transfected cultured cells
using the NH4
þ pulse method according to the formula
bi¼D[NH4þ ]i/DpHi.51 The experiments were performed
in the absence or the presence of CO2/HCO3
. Cells were
initially incubated in Naþ - and HCO3
-free solution and
monitored for pHi recording. The Na
þ - and HCO3
-free
solution was similar to the HCO3
-free solution that was used
for the pH studies, except that the NaCl was replaced with
iso-osmolar concentration of TMACl (tetramethylammo-
nium chloride). At steady-state pHi, addition of 20mmol/l
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NH4Cl (20mmol/l TMACl was replaced with 20mmol/l
NH4Cl) caused a rapid initial increase in cell pH because
of the influx of NH3 and subsequent generation of NH4
þ .
The total buffering capacity in the presence of HCO3
 (bT)
was estimated as the sum of bi and the bicarbonate buffer
capacity (bHCO3).
52
Chloride depletion studies
To deplete cells of intracellular chloride, transfected and non-
transfected cells were first pulsed with NH4Cl and then acid
loaded by switching to a chloride-free isotonic solution. After
generation of intracellular acidosis and achieving the nadir
pH, cells were switched to a chloride-free, Na-free hypotonic
solution as before. The chloride-free solution was prepared
by iso-osmolar replacement of TMACl with TMA-gluconate.
Cells were monitored for the Na-independent pHi recovery as
above.
Voltage clamping studies
Voltage clamp studies were performed by pre-incubating cells
with valinomycin (10 mmol/l).53 The experiments (36Cl efflux
or pHi recovery) were performed in the presence of a
potassium-rich solution.
Radioactive 36Cl flux studies
The influx and efflux of 36Cl in transfected cultured cells was
assayed as before.54 In brief, cells were pre-loaded with 36Cl
by pre-incubation with 2mmol/l 36Cl added to a solution
that contained 100mmol/l Na-gluconate, 30mmol/l K-gluco-
nate, and 10mmol/l Hepes at pH 7.5 for 60min. Thereafter,
the efflux of 36Cl into a low or high potassium-containing
solution (1 vs 16mEq) with or without extracellular chloride
(100 vs 0mmol/l) at normal or pH (7.4) was assayed. The
reaction was terminated at 10min using cold saline, and
radioactivity of cells was determined by liquid scintillation
spectroscopy.54 For influx studies, cells were incubated with
2mmol/l 36Cl-containing solution and uptake was assayed at
10min in the presence or the absence of 0.5mmol/l DIDS.
Materials
[32P]dCTP was purchased from New England Nuclear
(Boston, MA). Nitrocellulose filters and other chemicals
including valinomycin were purchased from Sigma (St Louis,
MO). A RadPrime DNA labeling kit was purchased from
Gibco-BRL (Carlsbad, CA). BCECF was obtained from
Molecular Probes. A mMESSAGE mMACHINE Kit was
purchased from Ambion (Austin, TX).
Statistical analysis
The results for radioactive flux, northern hybridization, or
pHi studies are presented as means±s.e. Statistical signifi-
cance between various experimental groups was determined
by ANOVA (analysis of variance) or Student’s unpaired t-test
whenever applicable. Po0.05 was considered significant
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